Background/Aim: The ultrasonic transit time is currently the best method for measuring the blood flow rate in the extracorporeal hemodialysis circuit. The purpose of this study was to analyze the differences between blood flow as indicated by the hemodialysis blood roller pump (prescribed blood flow) and by an ultrasonic flowmeter (delivered blood flow). Methods: The ultrasonic blood flow was measured in 20 patients on chronic hemodialysis who were dialyzed through an arteriovenous fistula. During each dialysis session the ultrasonic blood flow was measured at three different blood roller pump flow rates (300, 350, and 400 ml/min). In order to analyze the influence of inflow and outflow pressures on blood flow, this study was conducted during nine consecutive dialysis sessions during which needles of different sizes were used. Results: The ultrasonic flow was always lower than indicated by the blood roller pump: 265 ± 12, 304 ± 15, and 341 ± 19 ml/min for blood roller pump flow rates of 300, 350, and 400 ml/min, respectively (variability: –11.6, –13.1, and –14.8%, respectively). An univariate regression analysis showed that the reduction in flow recorded ultrasonically correlated with both venous blood line pressure (r = –0.2679, p < 0.001) and negative arterial blood line pressure (r = 0.6773, p < 0.001). By multivariate analysis, only the arterial blood line pressure has a predictive value. When all measurements were grouped by arterial blood line pressure ranges, the variability between ultrasonic blood flow and blood roller pump flow was found to be similar in those groups with the same arterial blood line pressure, regardless of the blood roller pump flow rate. Conclusions: The blood flow indicated by the dialysis blood roller pump is always greater than the delivered blood flow, and this difference is in turn conditioned by the negative pressure induced by the blood roller pump in the arterial blood line.

1.
Drost CJ, Thomas GG, Sellers AF: In vivo validation of the transit-time Ultrasonic volume flow meter. Proc 7th N Engl Bioeng Conf, Elmsford, Pergamon Press, 1981, pp 387–390.
2.
Burton RG, Gorewit RC: Ultrasonic flowmeter uses wide-beam transit-time technique. Med Electronics 1984;15:68–73.
3.
Krivitski NM: Novel method to measure access flow during hemodialysis by ultrasound velocity dilution technique. ASAIO J 1995;41:M741–M745.
4.
Depner ThA, Krivitski NM: Clinical measurement of blood flow in hemodialysis access fistulae and grafts by ultrasound dilution. ASAIO J 1995;41:M745–M749.
5.
Gleed RD, Harvey HJ, Dobson A: Validation in the sheep of an ultrasound velocity dilution technique for haemodialysis graft flow. Nephrol Dial Transplant 1997;12:1464–1467.
6.
Depner TA, Rizman S, Stasi TA: Pressure effects on roller pump blood flow during hemodialysis. ASAIO Trans 1990;36:M456–M459.
7.
Sands J, Glidden D, Jacavage W, Jones B: Difference between delivered and prescribed blood flow in hemodialysis. ASAIO J 1996;42:M717–M719.
8.
Barril G, Fdez Perpen A, Cirujeda A, Alvarez A, Bernis C, Schez Tomero JA, Traver JA, Selgas R: Valoración de método de tránsito ultrasónico y flujo/dilución para cálculo de flujo sangre en tiempo real, recirculatión y flujo del acceso vascular en las sesiones de HD (abstract). Nefrología 1998;XVIII(suppl 3):96.
9.
Hasbargen J, Weaver D, Hasbargen B: The effect of needle gauge on recirculation, venous pressure and bleeding from puncture sites. Clin Nephrol 1995;44:322–324.
10.
Gallego E, Portolés JM, Llamas F, Serrano A, Tallón S, Andrés E, Gómez C, Olivas E, Sánchez Tárraga L: Efecto del calibre de las agujas sobre la recirculación y la eficacia de la hemodiálisis. Nefrologia 1997;XVII:322–328.
11.
Schmidt DF, Schniepp BJ, Kurtz SB, McCarthy JT: Inaccurate blood flow rate during rapid hemodialysis. Am J Kidney Dis 1991;17:34–37.
12.
Shapiro W, Gurevich L: The effect of arterial needle size on dialyzer blood flow as measured by ultrasound dilution (abstract). J Am Soc Nephrol 1996;7:1419.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.